mcCormick Shawn 4

What Happened Shawn McCormick, a director of Inspire Medical Systems, was granted 3,562 restricted stock units (RSUs) on April 30, 2026. The Form 4 records this as an Award/Grant (code A) with an acquisition price of $0.00 — i.e., no cash exchanged. Each RSU is a contingent right to receive one share upon vesting; the grant itself does not represent immediately tradable shares.

Key Details

• Transaction date: 2026-04-30; Grant type: RSU award (A) for 3,562 units; acquisition price reported $0.00.
• Filing date: 2026-05-04 (filed on time — within the SEC’s 2 business-day Form 4 deadline).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote summary: RSUs vest on the earlier of (a) the first anniversary of the grant or (b) immediately prior to a Change of Control, and are subject to McCormick’s continued service through the vesting date.

Context RSU grants are a form of compensation for directors/executives and do not necessarily signal a personal purchase or sale decision. Value to the holder depends on Inspire’s stock price at vesting; tax withholding or share-for-share settlement may apply when RSUs vest. This transaction was a routine award rather than an open-market buy or sale.